Open Payments

John D. Archbold Memorial Hospital

Type
Teaching hospital
Where
THOMASVILLE, GA
Medicare CCN
110038
Received
$557,422 in 22 records, 2024 ($15,521 general, $541,900 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2024General payment3$15,521
2024Research payment19$541,900

By company

CompanyRecordsAmountYears
Novartis Pharmaceuticals Corporation1$399,1402024
Merck Sharp & Dohme LLC3$104,0682024
Celgene Corporation2$17,0002024
AngioDynamics, Inc.1$12,2772024
AstraZeneca UK Limited1$9,5002024
E.R. Squibb & Sons, L.L.C.4$7,7842024
Regeneron Pharmaceuticals, Inc.5$4,1332024
Stryker Corporation1$2,8352024
Becton, Dickinson and Company1$4082024
Genentech, Inc.3$2722024

By nature of payment

NatureRecordsAmount
Research payment19$541,900
Long term medical supply or device loan3$15,521

Records

DateCompanyAmountNatureFormProductStudyYear
2024-12-31Merck Sharp & Dohme LLC$34,689Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYAn Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatm2024
2024-12-31Merck Sharp & Dohme LLC$34,689Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pemb2024
2024-12-31Merck Sharp & Dohme LLC$34,689Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable 2024
2024-12-31AngioDynamics, Inc.$12,277Long term medical supply or device loanIn-kind items and servicesSolero Device, Oncology2024
2024-12-31Stryker Corporation$2,835Long term medical supply or device loanIn-kind items and servicesPOWER-PRO Device, EMS2024
2024-12-31Becton, Dickinson and Company$408Long term medical supply or device loanIn-kind items and servicesHemoSphere Vita Device, Hemodynamic Monitoring2024
2024-11-14E.R. Squibb & Sons, L.L.C.$1,040Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III Nivo+Ipi Combo in 1L Bladder (FA = OS Primary Study Cis-Ineligible)2024
2024-11-05Genentech, Inc.$90Research paymentCash or cash equivalentPH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC2024
2024-10-10Regeneron Pharmaceuticals, Inc.$408Research paymentCash or cash equivalentLIBTAYO Biological, ONCOLOGYCEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY2024
2024-09-05E.R. Squibb & Sons, L.L.C.$2,625Research paymentCash or cash equivalentConnect MM The Multiple Myeloma Disease Registry2024
2024-09-05Regeneron Pharmaceuticals, Inc.$617Research paymentCash or cash equivalentLIBTAYO Biological, ONCOLOGYCEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY2024
2024-08-15Regeneron Pharmaceuticals, Inc.$2,071Research paymentCash or cash equivalentLIBTAYO Biological, ONCOLOGYCEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY2024
2024-06-06Genentech, Inc.$90Research paymentCash or cash equivalentPH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC2024
2024-05-16Celgene Corporation$750Research paymentCash or cash equivalentConnect MM- The Multiple Myeloma Disease Registry2024
2024-05-02Regeneron Pharmaceuticals, Inc.$826Research paymentCash or cash equivalentLIBTAYO Biological, ONCOLOGYCEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY2024
2024-04-10Celgene Corporation$16,250Research paymentCash or cash equivalentPh I FIH mCRPC mono CC-94676-PCA-001 - A phase 1, multi-center, open-label, dose finding study to evaluate the safety, t2024
2024-03-27E.R. Squibb & Sons, L.L.C.$3,369Research paymentCash or cash equivalentOPDIVO Biological, OncologyA Phase 3, Randomized, Double-Blind Study of Nivolumab or Placebo in Combination With Docetaxel, in Men With Metastatic 2024
2024-03-13AstraZeneca UK Limited$9,500Research paymentCash or cash equivalentCAMBRIA-2 A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next G2024
2024-03-07E.R. Squibb & Sons, L.L.C.$750Research paymentCash or cash equivalentREVLIMID Drug, HematologyConnect MM- The Multiple Myeloma Disease Registry2024
2024-01-29Novartis Pharmaceuticals Corporation$399,140Research paymentCash or cash equivalentKISQALI Drug, OncologyA Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment 2024
2024-01-23Genentech, Inc.$90Research paymentCash or cash equivalentPH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC2024
2024-01-18Regeneron Pharmaceuticals, Inc.$209Research paymentCash or cash equivalentLIBTAYO Biological, ONCOLOGYCEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY2024

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Thomas CountyThomasville city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Thomasville, GA, county Thomas County, GA, state Georgia; placed by its city name.

MeasurePlace (city or town)
Thomasville, GA
County
Thomas County, GA
State
Georgia
Population B0100318,66645,77710,940,407
Population, 2020 census P118,88145,79810,711,908
Median age B0100238.639.837.6
Under 18 B0100122.8%23.6%23.2%
65 and over B0100120.6%19.0%15.0%
Households B110017,92918,6844,074,366
Foreign born B050022.7%2.7%11.2%
Median household income B19013$49,673$60,736$77,353
Median family income B19113$77,459$85,125$93,754
Per capita income B19301$35,327$33,700$40,924
Poverty rate B1700117.1%17.9%13.4%
Unemployment rate B230255.9%5.6%5.1%
Civilian labor force B230259,22322,5015,496,061
Mean commute (minutes) B0801316.320.128.3
Bachelor's degree or higher B1500324.9%22.7%34.9%
Housing units B250018,96521,1304,541,835
Owner-occupied B2500350.3%63.8%65.7%
Renters B2500349.7%36.2%34.3%
Median home value B25077$205,200$196,700$303,300
Median gross rent B25064$1,077$1,018$1,393
White, not Hispanic B0300239.6%57.0%49.1%
Black B0300253.5%34.9%30.7%
Hispanic or Latino B030022.1%3.9%11.0%
Asian B030020.6%0.9%4.5%
American Indian and Alaska Native B030020.1%0.2%0.1%

Economy now FRED unemployment 3.3% in Sep 2026 (3.4% a year earlier); per capita personal income $65,111 in 2025, up 26% in five years (+1.6% after inflation); Unemployment rate: 5.4% in Sep 2016 to 3.3% in Oct 2026; low 3.0%, high 12.5% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Thomasville, GA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.